rescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- Why I'm a pro-life liberal
- If a nuclear bomb exploded in downtown Washington, what should you do?
- 31 TV shows to watch in 2014
- He said he was leaving. She ignored him.
- Can these 4 couples really afford their dream houses?
- How to make homemade marshmallow Peeps
- What would a U.S.-Russia war look like?
- How to be more satisfied with your life, according to science
- There's a number of reasons the grammar of this headline could infuriate you
- 10 things you need to know today: April 16, 2014
Subscribe to the Week